Literature DB >> 16328570

Causal proportional hazards models and time-constant exposure in randomized clinical trials.

T Loeys1, E Goetghebeur, A Vandebosch.   

Abstract

The last decade saw enormous progress in the development of causal inference tools to account for noncompliance in randomized clinical trials. With survival outcomes, structural accelerated failure time (SAFT) models enable causal estimation of effects of observed treatments without making direct assumptions on the compliance selection mechanism. The traditional proportional hazards model has however rarely been used for causal inference. The estimator proposed by Loeys and Goetghebeur (2003, Biometrics vol. 59 pp. 100-105) is limited to the setting of all or nothing exposure. In this paper, we propose an estimation procedure for more general causal proportional hazards models linking the distribution of potential treatment-free survival times to the distribution of observed survival times via observed (time-constant) exposures. Specifically, we first build models for observed exposure-specific survival times. Next, using the proposed causal proportional hazards model, the exposure-specific survival distributions are backtransformed to their treatment-free counterparts, to obtain - after proper mixing - the unconditional treatment-free survival distribution. Estimation of the parameter(s) in the causal model is then based on minimizing a test statistic for equality in backtransformed survival distributions between randomized arms.

Mesh:

Year:  2005        PMID: 16328570     DOI: 10.1007/s10985-005-5233-z

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  8 in total

1.  Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.

Authors:  I R White; A G Babiker; S Walker; J H Darbyshire
Journal:  Stat Med       Date:  1999-10-15       Impact factor: 2.373

2.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

3.  Baseline information in structural failure time estimators for the effect of observed treatment compliance.

Authors:  T Loeys; E Goetghebeur
Journal:  Stat Med       Date:  2002-05-15       Impact factor: 2.373

Review 4.  Beyond intention to treat.

Authors:  Els Goetghebeur; Tom Loeys
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

5.  A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.

Authors:  T Loeys; E Goetghebeur
Journal:  Biometrics       Date:  2003-03       Impact factor: 2.571

6.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

7.  G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients.

Authors:  J M Robins; D Blevins; G Ritter; M Wulfsohn
Journal:  Epidemiology       Date:  1992-07       Impact factor: 4.822

8.  Estimating a treatment effect in survival studies in which patients switch treatment.

Authors:  Michael Branson; John Whitehead
Journal:  Stat Med       Date:  2002-09-15       Impact factor: 2.373

  8 in total
  7 in total

1.  Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none compliance.

Authors:  Robert M Elashoff; Gang Li; Ying Zhou
Journal:  Biometrika       Date:  2012-03-20       Impact factor: 2.445

2.  Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials.

Authors:  Peter B Gilbert; Bryan E Shepherd; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

3.  Instrumental variables estimation of exposure effects on a time-to-event endpoint using structural cumulative survival models.

Authors:  Torben Martinussen; Stijn Vansteelandt; Eric J Tchetgen Tchetgen; David M Zucker
Journal:  Biometrics       Date:  2017-05-10       Impact factor: 2.571

4.  Instrumental variable estimation in a survival context.

Authors:  Eric J Tchetgen Tchetgen; Stefan Walter; Stijn Vansteelandt; Torben Martinussen; Maria Glymour
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

5.  Instrumental variable approach for estimating a causal hazard ratio: application to the effect of postmastectomy radiotherapy on breast cancer patients.

Authors:  Fan Yang; Jing Cheng; Dezheng Huo
Journal:  Obs Stud       Date:  2019-10-18

6.  A semiparametric linear transformation model to estimate causal effects for survival data.

Authors:  Huazhen Lin; Yi Li; Liang Jiang; Gang Li
Journal:  Can J Stat       Date:  2013-11-14       Impact factor: 0.875

7.  On two-stage estimation of structural instrumental variable models.

Authors:  Byeong Yeob Choi; Jason P Fine; M Alan Brookhart
Journal:  Biometrika       Date:  2017-10-26       Impact factor: 3.028

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.